This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

DCF Advises on the Carve-out Acquisition of a Leading Vitamin and Nutritional Supplements Business

Transaction Highlights Cross-Border Experience in Health & Wellness

Deloitte Corporate Finance LLC (DCF) is pleased to announce its role as the exclusive buy-side financial advisor for the acquisition by International Vitamin Corporation (IVC) of Inverness Medical Innovations’ vitamin and nutritional supplements business. IVC acquired the assets of the business, which included manufacturing facilities in Freehold and Irvington, New Jersey, in a cash transaction valued at approximately $63.4 million.

DCF was engaged to assist with the development of the target approach strategy and IVC value drivers, analytical modeling, and transaction support. Key relationships and cross-functional service offerings were crucial factors in successfully executing the transaction on an expedited timeline. This transaction further highlights DCF’s experience in executing complex cross-border transactions.

International Vitamin Corporation
IVC and its affiliates engage in the manufacturing, packaging, sale, and distribution of branded and private-label vitamins, herbs, nutritional supplements, and Rx and OTC drug products. The company markets more than 500 different products, packaged under various labels and bottle counts in tablets, powders, two-piece hard-shell capsules, and soft gelatin encapsulated capsules.

Inverness Medical Innovations
Inverness Medical Innovations is a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management. Inverness develops new capabilities in near-patient diagnosis, monitoring and health management.

Stay Connected